MOUNTAIN VIEW, Calif. — Omnicell announced the results of the STOMPP (Study to Measure the Impact of Pharmacists and Pharmacy Services on Medication Non-Adherence) clinical study. This randomized controlled trial compares the use of adherence medication packaging and medication therapy management (MTM) services to the use of traditional pill bottles. The results indicate a clear improvement in clinical outcomes and adherence rates when using multimed blister card packaging and MTM services.
In the STOMPP study, patients were randomly assigned to one of four groups based on whether they received their medications dispensed in vials (pill bottles) vs. multimed blister packaging, and whether or not they received pharmacist-provided MTM. While improvements with use of multimed packaging and MTM services were proven individually and in combination, study participants who received multimed blister cards had the most marked change in adherence scores when compared to pill bottle groups, achieving adherence scores greater than 45% above baseline.
Further evidence of the benefits of multimed packaging as demonstrated by the STOMPP study is highlighted below:
- Patients assigned to the multimed packaging groups reached medication adherence rates of 80% almost immediately upon enrollment.
- These patients achieved 90 percent adherence rates by the end of the one-year study period.
- By contrast, patients assigned to the pill bottle-only group reached a maximum of 56% adherence.
To combat the $290 billion problem of medication nonadherence, innovative pharmacies must employ a variety of tools designed to change patient behavior. Omnicell is committed to helping resolve this crisis through a comprehensive portfolio of solutions that are part of the company’s integrated medication management platform. These include the market-leading Time My Meds medication synchronization software, Pharmacy Line Interactive Voice Response, SureMed Multimed Blister Cards, Guided Packing, and automated packaging systems, including the VBM 200F and the M5000. This unique set of solutions is enabled through Omnicell’s Patient Management Access Portal (PMAP), web-based software that centralizes all patient engagement.
“As a nation, we need to do a better job at managing complex patients, as 80 million patients are expected to have more than one chronic condition by 2030,” said Dr. Sharrel Pinto, division head and associate professor of Health Outcomes and Socioeconomic Sciences of the University of Toledo College of Pharmacy and Pharmaceutical Sciences and Director of the Pharmaceutical Care and Outcomes Research (PCOR) laboratory. “STOMPP reinforces the adherence pharmacy model, and affirms the value of the pharmacist as a key member of the care team in not only improving the experience and health of these patients, but also reducing the overall costs associated with their care. Using the arsenal of tools now available to this industry, including medication synchronization technology and blister packaging, pharmacists can help patients significantly impact their health.”
Comments are closed.